Derma Sciences Inc. (DSCI) Swings to Q4 Profit
Derma Sciences Inc. (NASDAQ: DSCI) reports Q4 EPS of $0.01, versus $0.12 reported for the same period a year ago. Revenue for the quarter was $13.65 million, compared to $12.56 million in Q408.
You May Also Be Interested In
- Caterpillar (CAT) Reports World Machine Sales Down 18% in Sept.
- Cadence Design Systems (CDNS) Tops Q3 EPS by 2c, Offers Q4 Guidance
- Avalonbay Communities (AVB) Reports In-Line Q3 FFO
Create E-mail Alert Related CategoriesEarnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!